The Austrian Financial Market Authority (FMA) approved 29 prospectuses in the second quarter of 2014. The FMA thus allowed a maximum volume of roughly € 54.5 billion to be issued (Q2 2013: € 21.3 billion). In addition, 44 supplements were approved, and one approval procedure was withdrawn by the issuer and subsequently discontinued. During the same period in 2013, 29 prospectuses and 11 supplements had been approved, and one approval procedure discontinued. These figures were disclosed in the Q2 Report on Austrian Supervision of Capital Market Prospectuses, published today by the FMA.
Prospectuses from 23 issuers were approved between 1 April and 30 June (Q2 2013: 22). When broken down according to the various categories of issuers, approvals were distributed as follows (with the figure for Q2 2013 in parentheses): IPOs, capital increases and listing prospectuses 3 (2), housing banks 3 (3), basis prospectuses 16 (15) and bonds 1 (2).
In order to use a prospectus or a supplement in another EEA Member State, a notification must first be sent to the competent authority of the particular country. In Q2 2014 sister authorities notified the FMA of 136 prospectuses (Q2 2013: 183) and 332 supplements (Q2 2013: 799). The FMA provided notification of 12 prospectuses (15) and 31 supplements (3).
In response to infringements of the Capital Market Act, the FMA imposed two administrative penalties (2) and reported one case to the public prosecutor’s office (0) in Q2 2014.
The full Quarterly Report can be found (in German) on the FMA website at: https://www.fma.gv.at/kapitalmaerkte/aufsicht-ueber-kapitalmarktprospekte/quartalsberichte/
Journalists may address further enquiries to:
Klaus Grubelnik (FMA Media Spokesperson)
+43/(0)1/24959-6006
+43/(0)676/882 49 516